Drug Type Recombinant protein, Prophylactic vaccine |
Synonyms 2019(RBD二聚体亚单位SARS-CoV-2疫苗), 重组新型冠状病毒疫苗(CHO细胞), Y 2019 + [1] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 2 | - | - |